Bill116th CongressFiled Jul 30, 2019Health
H.R. 4106
Responsibility in Drug Advertising Act of 2019
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 30, 2019)
Responsibility in Drug Advertising Act of 2019
This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.What just happenedJul 31, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. DeLauro, Rosa L. [D-CT-3](D-CT)Sponsor
3 cosponsors3 D
3cosponsors1committees4actions2related bills3subjects
- Introduced in HouseJul 30, 2019
- Jul 31, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 30, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 30, 2019IntroReferralIntro-H
Introduced in House
- Jul 30, 2019IntroReferral1000
Introduced in House